FDA Webview
    
    
    
    
    
    
    
    
        
                        
                                    
                                    
                Biologics
                FDA accepts for filing Ilex Oncology's 12/23/99 BLA for Campath (alemtuzumab), an investigational hu...
                
                
             
                            
                                    
                                    
                Biologics
                FDA posts its agenda for an upcoming public meeting on spine and other orthopedic use of human bone ...
                
                
             
                            
                                    
                                    
                Biologics
                FDA's Center for Biologics Evaluation and Research yesterday posted the review and approval document...
                
                
             
                            
                                    
                                    
                Biologics
                CBER says Alpha Therapeutic Corp. has requested that all stock of two lots of its immune globulin in...
                
                
             
                            
                                    
                                    
                Biologics
                CBER has cleared Baxter Healthcare's 510(k) application for its Sepacell pre-storage leukocyte reduc...
                
                
             
                            
                                    
                                    
                Biologics
                FDA has granted priority review status to Wyeth Lederle Vaccines' investigational pneumococcal conju...
                
                
             
                            
                                    
                                    
                Biologics
                Coulter Pharmaceutical and SmithKline Beecham say FDA has granted priority review for Bexxar (tositu...
                
                
             
                            
                                    
                                    
                Biologics
                Stryker Corp. says FDA has accepted for filing its PMA for the OP-1 Implant to treat long bone union...
                
                
             
                            
                                    
                                    
                Biologics
                FDA sends Aeglea BioTherapeutics a refusal-to-file letter for its BLA for pegzilarginase, indicated ...
                
                
             
                            
                                    
                                    
                Biologics
                Some 18 members of Congress ask FDA 19 questions about Covid-19 vaccine safety in children under age...
                
                
             
                            
                                    
                                    
                Biologics
                FDA delays making a decision on Novavaxs Covid-19 vaccine emergency use authorization request after ...
                
                
             
                            
                                    
                                    
                Biologics
                As FDA prepares for a 6/14-15 advisory committee meeting on pediatric Covid-19 vaccines, agency brie...
                
                
             
                            
                                    
                                    
                Biologics
                CBER updates its guidance agenda for 2022 containing 18 guidances it plans to develop.
                
                
             
                            
                                    
                                    
                Biologics
                An FDA advisory committee votes unanimously (22 to 0) to recommend the agency grant Moderna an emerg...
                
                
             
                            
                                    
                                    
                Biologics
                Krystal Biotech files a BLA for B-Vec (beremagene geperpavec), a topical gene therapy for treating p...
                
                
             
                            
                                    
                                    
                Biologics
                FDA publishes a draft guidance on the voluntary consensus standards recognition program for regenera...
                
                
             
                            
                                    
                                    
                Biologics
                FDAs Vaccines and Related Biological Products Advisory Committee unanimously votes to recommend the ...
                
                
             
                            
                                    
                                    
                Biologics
                Six stakeholders provide comments to FDA on the agencys docket on human gene therapy products incorp...
                
                
             
                            
                                    
                                    
                Biologics
                FDA authorizes Modernas Covid-19 vaccine and Pfizer-BioNTechs Covid-19 vaccine for use in children a...
                
                
             
                            
                                    
                                    
                Biologics
                FDA denies a petition from the Informed Consent Action Network asking that it not approve Covid-19 v...